Advertisement
Advertisement
ALC
Alcon Inc. Ordinary Shares
69.83
USDSponsored
+0.41
+0.59%
Oct 28, 15:59 UTC -4
Closed
After-Market
69.81
-0.02
-0.04%
Alcon Inc. Ordinary Shares (ALC) Earnings
ALC Earnings Reports
Positive Surprise Ratio
ALC beat 21 of 30 last estimates.
70%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.77B
/$0.88
Implied change from Q2 26 (Revenue/ EPS)
-0.51%
/+4.76%
Implied change from Q3 25 (Revenue/ EPS)
+6.90%
/+11.39%
Alcon Inc. Ordinary Shares earnings per share and revenue
On Aug 10, 2026, ALC reported earnings of 0.84 USD per share (EPS) for Q2 26, beating the estimate of 0.76 USD, resulting in a 10.51% surprise. Revenue reached 2.78 billion, compared to an expected 2.80 billion, with a -0.53% difference. The market reacted with a -2.35% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.88 USD, with revenue projected to reach 2.77 billion USD, implying an increase of 4.76% EPS, and decrease of -0.51% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
Glaukos Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.09
Actual
$0.47
Surprise
+611.98%
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
Axogen, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.14
Actual
$0.21
Surprise
+47.06%
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
ClearPoint Neuro, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.30%
FAQ
What were Alcon Inc. Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Alcon Inc. Ordinary Shares reported EPS of $0.84, beating estimates by 10.51%, and revenue of $2.78B, -0.53% below expectations.
How did the market react to Alcon Inc. Ordinary Shares's Q2 2026 earnings?
The stock price moved down -2.35%, changed from $75.35 before the earnings release to $73.58 the day after.
When is Alcon Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Alcon Inc. Ordinary Shares's next earnings report?
Based on 7
analysts, Alcon Inc. Ordinary Shares is expected to report EPS of $0.88 and revenue of $2.77B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.